Clinical Trials Directory

Trials / Completed

CompletedNCT00000248

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Dose Response Trial of Pergolide for Cocaine Dependence

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
0 (planned)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Conditions

Interventions

TypeNameDescription
DRUGPergolide

Timeline

Start date
1996-02-01
First posted
1999-09-21
Last updated
2018-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000248. Inclusion in this directory is not an endorsement.

Dose Response Trial of Pergolide for Cocaine Dependence - 1 (NCT00000248) · Clinical Trials Directory